Ichor Therapeutics is a privately held vertically integrated pre-clinical contract research organization based in LaFayette, New York. It broadly focuses on the study of aging and aging pathways. The core competencies of the company include, protein engineering, laboratory automation, stem cell biology, and lab animal husbandry. Ichor also has created several portfolio companies that are supported by venture capital and intramural funding. The companies are:
A pre-clinical biotechnology company that develops antibody mimetics for therapeutic and diagnostic applications. It's main product is the RPtag, an antibody mimetic scaffold based on a ribose-binding protein from the extremophile Caldanaerobacter subterraneus. Founded in 2018, the company is pursuing targets in extreme anatomical environments like the gut, where antibodies cannot be used.
A pre-clinical biotechnology company that develops enzyme therapies for eye disease. The company is developing leads to treat atrophic 'dry' age-related macular degeneration (AMD) and Stargardt's macular degeneration (SMD). Lysoclear is a recombinant enzyme product that is able to selectively localize to the lysosomes of RPE (retinal pigmental epithelial) cell death where toxic vitamin A aggregates accumulate, and destroy them. It operates identically to existing LSD (lysosomal storal disease) therapies, but instead of replacing defective enzymes, a new enzyme is introduced that upgrades RPE cells with the ability to degrate A2E and other lipofuscin components.
A biotechnology company which provides protein expression and purification technologies.
Antoxerene is a pharmaceutical company that uses proprietary screening technology to identify small molecule drugs for pathways of aging.
A life sciences strategic fund and accelerator program that provides up to $100,000 in seed funding, technical training, full access to Ichor's research laboratory, and mentorship to life science entrepreneurs in exchange for equity.
Ichor also offers a range of services directly or through its portfolio companies that are catered towards pharmaceutical and biotechnology companies. They include:
- GMP complaince
- Senolytic research
- Surgical models
- Xenograft models
- GLP compliance
- Rodent husbandry
- Stem cell research
- Protein engineering
- Lifespan studies
- Drug discovery
Chief Scientific Officer
Cornelis (Cees) Wortel
Chief Medical Officer
Founder & CEO
Quality Assurance Director
Drug researcher Ichor Therapeutics to expand in LaFayette, add 14 jobs
Ichor's Auctus Biologics Closes Quick $1.5MM
Documentaries, videos and podcasts